Client News

Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH

VAXIMM AG to Participate at Upcoming Industry Events

nova funds GmbH: Gesundheitsaktienfonds nova Steady HealthCare mit FundAward 2020 ausgezeichnet

Abivax to Host Satellite Symposium at 15th Congress of the European Crohn’s and Colitis Organization (ECCO) in Vienna

AFFiRiS Announces FDA Response to its pre-IND Submission for Phase 2 Trial with AFFITOPE® PD01 in Early Parkinson’s Disease Patients

4basebio AG decides to buy back 2 million treasury shares

Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB

Abivax receives clearance from U.S. FDA to initiate clinical trials with ABX464 to treat moderate to severe ulcerative colitis

Abivax: 2020 Financial Communication Calendar

nova funds GmbH: Gesundheitsaktienfonds nova Steady HealthCare setzt ausgezeichnete Wertentwicklung fort